“I was able to
connect with a Patient Central Associate who provided a wealth of
knowledge on clinical trials, survivor contacts and physician
information. Through this, my family found a renowned pancreatic cancer
oncologist and my mother received top-notch care for 8 months until her
passing in February of 2014.”

In addition to local supporters and survivors, PurpleStride New York
City will welcome “Good Morning America” weekend news anchor Ron
Claiborne and former “Survivor” cast member and season 24 finalist
Katrina Edorsson.

Pancreatic cancer is the nation’s deadliest major cancer, with a
five-year survival of just 9
percent. As the go-to organization supporting pancreatic cancer
patient services and research, the Pancreatic Cancer Action Network
(PanCAN) has an urgent mission to improve outcomes for patients battling
the disease today and to double pancreatic cancer survival by 2020.

PurpleStride is a national movement that is transforming the face of
pancreatic cancer. Each year, more than 80,000 people in cities across
the U.S. participate in PurpleStride 5K walk/run events to raise funds
for the organization’s key initiatives, including Precision
Promise, Know
Your TumorSM and the Patient
Registry. PurpleStride has raised more than $76 million since 2008.

Lin Sun, spokesperson for the New York City PanCAN Affiliate, knows
first-hand how important these resources are for families who have been
touched by this disease.

"I found the Pancreatic Cancer Action Network online after my mother was
diagnosed with the disease, and it turned out be more helpful and
meaningful than I ever could have imagined,” Sun said. “I was able to
connect with a Patient Central Associate who provided a wealth of
knowledge on clinical trials, survivor contacts and physician
information. Through this, my family found a renowned pancreatic cancer
oncologist and my mother received top-notch care for 8 months until her
passing in February of 2014."

The Pancreatic Cancer Action Network (PanCAN) is the global leader
accelerating the pace of research progress for one of the world’s
deadliest cancers. With an urgent mission to improve outcomes for
pancreatic cancer patients and double survival by 2020, the
organization, founded in 1999, executes a bold and comprehensive
strategy to Wage Hope through research, patient services, advocacy and
community engagement. The organization’s visionary goals, world-class
programs and services, extensive grassroots network, patient-focused
outcomes and advisory board of scientific and medical leaders provide
the critical backdrop to help pancreatic cancer patients today and
create transformational change for all patients in the future.